Вы находитесь на странице: 1из 1

NURS 1566 Clinical Form 3: Clinical Medications Worksheets

(You will need to make additional copies of these forms)

Generic Name Trade Name Classification Dose Route Time/frequency


propoxyphene Darvocet-N opioid analgesics 100 mg PO Q 4 hours PRN
napsylate/
acetaminophen
Peak Onset Duration Normal dosage range
2-3 hr 15-60 min 4-6 hr 50-100 mg

Why is your patient getting this medication For IV meds, compatibility with IV drips and/or solutions
Pain with rt. Hip fracture

Mechanism of action and indications Nursing Implications (what to focus on)


(Why med ordered) Contraindications/warnings/interactions
Mild to moderate pain, Binds to opiate receptors in the CNS Appears on Beers list. Elderly or debilitated patients require
Alters the perception of and response to painful stimuli, while reduced dosages, Undiagnosed abdominal pain, Hypothyroidism,
producing, generalized CNS depression
Common side effects
dizziness, weakness, nausea

Interactions with other patient drugs, OTC or herbal medicines (ask Lab value alterations caused by medicine
patient specifically) May cause increase in serum amylase and lipase levels, May cause
Other opioid analgesics and sedative/hypnotics increase in AST, ALT, serum alkaline phosphatase, LDH, and
bilirubin
Be sure to teach the patient the following about this medication
Instruct patient on how and when to ask for pain medication
Encourage patient to turn, cough, and breathe deeply every
2 hr to prevent atelectasis, Advise patient to change positions
slowly to minimize ,orthostatic hypotension, Advise patient that
good oral hygiene, frequent mouth rinses, and sugarless gum or
candy may decrease dry mouth
Nursing Process- Assessment Assessment Evaluation
(Pre-administration assessment) Why would you hold or not give this med? Check after giving
Assess type, location, and intensity of pain prior to and Assess blood pressure, pulse, and Decrease in severity of pain
2 hr following admin. Assess bowel function routinely. respirations before and periodically without a significant
Prevention of constipation should be instituted with during administration. If respiratory rate alteration in level of
increased intake of fluids and bulk, is <10/min, assess level of sedation. consciousness
and laxatives to minimize constipating effects. Physical stimulation may be sufficient to
Stimulant laxatives should be administered routinely if prevent significant hypoventilation. Dose
opioid use exceeds 2-3 days, unless contraindicated. may need to be decreased by 25-50%.
monitor closely and assess falls risk Initial drowsiness will diminish with
continued use